Indefinite Delivery Contract SPM2DX14D0962

This indefinite delivery contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military healthcare facilities worldwide under the TRICARE West program.

Through this IDC, DMS Pharmaceutical Group provides a vast array of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and consumables. The firm fixed-price delivery orders issued under the contract cover both routine and specialized pharmaceuticals, such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, oncology drugs, and specialty medications. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's woman-owned small business status to secure this direct award. The period of performance runs through December 31, 2025, with the company serving as a critical supplier in the federal pharmaceutical supply chain supporting the Department of Defense's medical requirements.